200 related articles for article (PubMed ID: 18807293)
1. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of patients with yolk sac tumors of the ovary.
Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
[TBL] [Abstract][Full Text] [Related]
3. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of patients with ovarian yolk sac tumors: a study in Chinese patients.
Tong X; You Q; Li L; Cai L; Wang C; Zheng J
Onkologie; 2008 Dec; 31(12):679-84. PubMed ID: 19060506
[TBL] [Abstract][Full Text] [Related]
5. Yolk sac tumours of the ovary: an update.
Dällenbach P; Bonnefoi H; Pelte MF; Vlastos G
Eur J Surg Oncol; 2006 Dec; 32(10):1063-75. PubMed ID: 16996238
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Yolk Sac Tumors; Does Age Matter?
Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
[TBL] [Abstract][Full Text] [Related]
7. Yolk sac tumor of the vulva: a case report with long-term disease-free survival.
Khunamornpong S; Siriaunkgul S; Suprasert P; Chitapanarux I
Gynecol Oncol; 2005 Apr; 97(1):238-42. PubMed ID: 15790466
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary.
Palenzuela G; Martin E; Meunier A; Beuzeboc P; Laurence V; Orbach D; Frappaz D
Ann Surg; 2008 Nov; 248(5):836-41. PubMed ID: 18948812
[TBL] [Abstract][Full Text] [Related]
9. Endodermal sinus tumor of the ovary: the Hacettepe University experience.
Ayhan A; Taskiran C; Bozdag G; Altinbas S; Altinbas A; Yuce K
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):230-4. PubMed ID: 16026921
[TBL] [Abstract][Full Text] [Related]
10. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
11. Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.
Sehouli J; Drescher FS; Mustea A; Elling D; Friedmann W; Kühn W; Nehmzow M; Opri F; Klare P; Dietel M; Lichtenegger W
Anticancer Res; 2004; 24(2C):1223-9. PubMed ID: 15154651
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases.
de La Motte Rouge T; Pautier P; Rey A; Duvillard P; Kerbrat P; Troalen F; Morice P; Haie-Meder C; Culine S; Lhommé C
Eur J Cancer; 2011 Jan; 47(2):175-82. PubMed ID: 20851596
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
[TBL] [Abstract][Full Text] [Related]
14. Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.
Kommoss F; Schmidt M; Merz E; Knapstein PG; Young RH; Scully RE
Gynecol Oncol; 1999 Mar; 72(3):421-4. PubMed ID: 10053117
[TBL] [Abstract][Full Text] [Related]
15. The prognostic and predictive value of syntactic structure analysis in serous carcinoma of the ovary.
Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Janssen EA; Baak JP; Rollason TP
Int J Gynecol Pathol; 2008 Apr; 27(2):191-8. PubMed ID: 18317224
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in adult granulosa cell tumor of the ovary.
Li W; Wu X; Fang C; Yao J; Guo Y; Zhang S
Saudi Med J; 2009 Feb; 30(2):247-52. PubMed ID: 19198715
[TBL] [Abstract][Full Text] [Related]
18. Yolk sac tumor of the ovary: a retrospective multicenter study of 33 Japanese women by Tohoku Gynecologic Cancer Unit (TGCU).
Kojimahara T; Nakahara K; Takano T; Yaegashi N; Nishiyama H; Fujimori K; Sato N; Terada Y; Tase T; Yokoyama Y; Mizunuma H; Shoji T; Sugiyama T; Kurachi H
Tohoku J Exp Med; 2013 Aug; 230(4):211-7. PubMed ID: 23912096
[TBL] [Abstract][Full Text] [Related]
19. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.
Hölscher G; Anthuber C; Bastert G; Burges A; Mayr D; Oberlechner E; Schubert-Fritschle G; Sinz S; Sommer H; Schmalfeldt B; Engel J;
Acta Obstet Gynecol Scand; 2009; 88(4):440-8. PubMed ID: 19191075
[TBL] [Abstract][Full Text] [Related]
20. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
